Clinical onset and course, response to treatment and outcome in 24 patients with the cblE or cblG remethylation defect complemented by genetic and in vitro enzyme study data.

Date
2015
Author
Fowler, B.
Huemer, M.
Augoustides-Savvopoulou, P.
Suormala, T.
Buerer, C.
Lorenzl, S.
Lotz-Havla, A. S.
Noss, J.
Parini, R.
Peters, H.
Plecko, B.
Ramos, F. J.
Schlune, A.
Tsiakas, K.
Tansek, M. Zerjav
Baumgartner, M. R.
Gokcay, Gülden Fatma
Jesina, P.
Kozich, V.
Landolt, M. A.
Koch, J.
Jardine, P.
Hennermann, J.
De Meirleir, L.
Broomfield, A.
Brennerova, K.
Blair, E.
Metadata
Show full item record
Abstract
Background The cobalamin E (cblE) (MTRR, methionine synthase reductase) and cobalamin G (cblG) (MTR, methionine synthase) defects are rare inborn errors of cobalamin metabolism leading to impairment of the remethylation of homocysteine to methionine.
URI
http://hdl.handle.net/20.500.12627/107912
https://doi.org/10.1007/s10545-014-9803-7
Collections